Earnings Feed
Start Free
Home/Filings/4/0001209191-17-054555
4//SEC Filing

CAUWENBERGH GEERT 4

Accession 0001209191-17-054555

CIK 0001533040other
View on SEC.govCompany Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 3:44 PM ET

Size

9.3 KB

Accession

0001209191-17-054555

Insider Transaction Report

Form 4
Period: 2017-10-02
RXi Pharmaceuticals CorpRXII
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
  • Purchase

    Common stock, $0.0001 par value

    2017-10-02$0.44/sh+2,700$1,188→ 135,283 total
  • Purchase

    Common stock, $0.0001 par value

    2017-10-02$0.46/sh+200$92→ 135,483 total
  • Purchase

    Common stock, $0.0001 par value

    2017-10-02$0.45/sh+7,100$3,195→ 142,583 total
Holdings

  • Common stock, $0.0001 par value

    (indirect: By Spouse)
    4,500

  • Common stock, $0.0001 par value

    (indirect: By son)
    450
Footnotes (1)
  • [F1]Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shall not constitute an admission of beneficial ownership.

Documents

1 file

Issuer

RXi Pharmaceuticals Corp

CIK 0001533040

→
Entity typeother

Related Parties

1
  • filerCIK 0001285648

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 3:44 PM ET
Size
9.3 KB
View on SEC.gov